M&A

Elan says Amarin deal 'still an opportunity we are considering'

Elan says Amarin deal 'still an opportunity we are considering'

The Fly on the Wall

GlaxoSmithKline has some good news, but no one seems to hear

GlaxoSmithKline has some good news, but no one seems to hear

Marketwatch

Bayer receives antitrust clearance from FTC for its acquisition of Conceptus

Bayer receives antitrust clearance from FTC for its acquisition of Conceptus

Yahoo/AP

Glaxo Buys Okairos for $324 Million to Grow in Vaccines

Glaxo Buys Okairos for $324 Million to Grow in Vaccines

Bloomberg

Amarin slumps as AstraZeneca buys potential rival

Amarin slumps as AstraZeneca buys potential rival

Yahoo/AP

Omthera shares up 89% after AstraZeneca deal

Omthera shares up 89% after AstraZeneca deal

Marketwatch

Big Pharma Wants Fish Oil After All, But At Half Amarin's Selling Price

Big Pharma Wants Fish Oil After All, But At Half Amarin's Selling Price

TheStreet.com

Sun Pharma rallies on German firm buyout buzz

Sun Pharma rallies on German firm buyout buzz

Economic Times, India

Valeant pays $8.7 billion for Bausch & Lomb

Valeant pays $8.7 billion for Bausch & Lomb

CNN Money

Valeant Reportedly Nearing Deal To Buy Bausch & Lomb For $9 Bln

Valeant Reportedly Nearing Deal To Buy Bausch & Lomb For $9 Bln

NASDAQ